Rapid-eye movement (REM) sleep correlates with neuronal activity in the brainstem, basal forebrain and lateral hypothalamus. Lateral hypothalamus melanin-concentrating hormone (MCH)-expressing neurons are active during sleep, but their effects on REM sleep remain unclear. Using optogenetic tools in newly generated Tg(Pmch-cre) mice, we found that acute activation of MCH neurons (ChETA, SSFO) at the onset of REM sleep extended the duration of REM, but not non-REM, sleep episodes. In contrast, their acute silencing (eNpHR3.0, archaerhodopsin) reduced the frequency and amplitude of hippocampal theta rhythm without affecting REM sleep duration. In vitro activation of MCH neuron terminals induced GABA A -mediated inhibitory postsynaptic currents in wake-promoting histaminergic neurons of the tuberomammillary nucleus (TMN), and in vivo activation of MCH neuron terminals in TMN or medial septum also prolonged REM sleep episodes. Collectively, these results suggest that activation of MCH neurons maintains REM sleep, possibly through inhibition of arousal circuits in the mammalian brain. npg
REM sleep, or paradoxical sleep 1 , is characterized by rapid eye movements, muscle atonia and prominent theta rhythm in the hippo campus and cortex 2 . Pioneering studies initially located the REM sleep 'generator(s)' in the pons 1 , where reciprocal inhibition between cholinergic neurons and serotonergic neurons from raphe nuclei and noradrenergic neurons from locus coeruleus were originally hypo thesized to gate REM sleep [3] [4] [5] [6] [7] . More recently, neurons producing the neurotransmitter GABA and glutamate were integrated into the brainstem circuitry that is critical for the onset of REM sleep [8] [9] [10] [11] . In addition, the activity of neurons outside the brainstem also correlates with REM sleep state 12 , including neurons located in the anterior 13 and lateral [14] [15] [16] parts of the hypothalamus. Collectively, these stud ies suggested that the lateral hypothalamus networks are involved in regulating REM sleep states, but causal evidence is missing.
We investigated the role of neurons producing the MCH peptide in regulating REM sleep state. Pharmacological infusion of the MCH peptide 15, 17 and selective activation of a subset of MCH neurons 18 induced both nonREM (NREM) and REM sleep. MCH neurons are strongly activated during a homeostatic sleep rebound induced by a prolonged sleep deprivation 14, 15, 19, 20 and discharge maximally dur ing REM sleep, but are silent during NREM and wake episodes 21 . However, mice with a genomic deletion of Pmch (ref. 22) and Mchr1 (ref. 23 ) had discrepant phenotypes. Thus, it remains unclear whether MCH neurons are causally involved in the regulation of REM sleep. To characterize the role of the MCH neurons in regulating REM sleep state, we generated a new transgenic mouse model, Tg(Pmch-cre), and took advantage of recently developed activating and silencing opsins to manipulate the activity of lateral hypothalamus MCH neurons with high temporal resolution in behaving mice.
RESULTS

Genetic targeting of lateral hypothalamus MCH neurons
To target optogenetic actuators to MCH neurons located in the lateral hypothalamus and the zona incerta area, we generated a Tg(Pmchcre) mouse using bacterial artificial chromosome (BAC) technology in which cre is driven by a ~108kb fragment of the Pmch gene pro moter ( Fig. 1a) . To assess the selectivity of this transgene, we crossed Tg(Pmchcre) mice with Credependent tdTomato reporter (Rosa CAGLSLtdTomatoWPRE) and found that 83.6 ± 4.1% of MCH immunopositive cells expressed TdTomato in the lateral hypothalamus, whereas 97.9 ± 0.4% of TdTomato cells expressed MCH peptide ( Fig. 1b and Online Methods). After stereotactic injection of Cre inducible adenoassociated virus AAVdjEF1DIOChETAEYFP [24] [25] [26] into the lateral hypothalamus and zona incerta of Tg(Pmchcre) mice ( Fig. 1c) , we found that 87.67 ± 2.96% of MCHimmunopositive cells coexpressed ChETAEYFP (1,672 of 1,912 cells, three sections per mouse, n = 6 mice), and MCH immunoreactivity could be detected in 89.65 ± 1.08% of ChETAEYFP expressing cells (1,672 of 1,852 cells, three sections per mouse, n = 6 mice) ( Fig. 1d) . No EYFP fluorescence was observed in wildtype (Cre negative) mice following virus transduc tion, confirming that the expression was selective for Creexpressing neurons. ChETAEYFP expression persisted as long as 6 months, and we observed dense ChETAEYFP-containing MCH terminals in the hypothalamus, septum, raphe nucleus, locus coeruleus and cortex, con sistent with previous characterizations 27 (Supplementary Fig. 1) .
To test the response of ChETAexpressing MCH neurons to optical stimuli, we performed wholecell patchclamp recordings in acute hypothalamic slices ( Fig. 1e-j) . As previously reported for wildtype MCH neurons 28, 29 , ChETAEYFP-expressing MCH neurons were 1 6 3 8 VOLUME 16 | NUMBER 11 | NOVEMBER 2013 nature neurOSCIenCe a r t I C l e S not spontaneously active and retained typical resting membrane potential (−61.7 ± 1.4 mV) and input resistance (428.0 ± 63.1 MΩ) ( Fig. 1e) . Blue light illumination (473 nm) evoked inward photocur rents (−158.2 ± 25.8 pA; Fig. 1f,g) , and brief pulses of light (1-10 ms) evoked single action potentials ( Fig. 1h) at frequencies of up to 20 Hz with high fidelity (Fig. 1i,j) . Extracellular recording in anesthetized mice confirmed that optogenetic stimulation of lateral hypothalamus MCH neurons evoked spike waveforms similar to spontaneous wave forms ( Supplementary Fig. 2 ).
Activation of MCH neurons stabilizes REM sleep
In mammals, sleep is not homogeneous, but comprises a progres sion through various states, including NREM and REM sleep. After the onset of NREM sleep, mice switch to either wake or REM sleep states 7 . REM sleep episodes typically terminate by a transition to wakefulness. To probe the role of MCH neurons in different stages of sleep, we transduced Tg(Pmchcre) mice with AAVdjEF1DIO ChETAEYFP (ChETA) or AAVdjEF1DIOEYFP (control) viruses and implanted electroencephalographic (EEG) and electromyo graphic (EMG) electrodes, as well as bilateral optical fibers above the lateral hypothalamus and zona incerta area (Online Methods). Genetic and viral manipulations did not disrupt spontaneous sleep wake cycles ( Supplementary Fig. 3) , and experiments were con ducted during the second half of the light phase (12-7 p.m.), when REM sleep episodes were most frequent. To investigate the effects of MCH cell activity on NREM and REM sleep, we started optical Supplementary Fig. 4 ). Note that optogenetic stimulation patterns (1-20 Hz) were consistent with spontaneous discharge of MCH neurons during REM sleep 21 . We found that optogenetic stimulation of MCH neurons at 20 or 1 Hz at the onset of NREM sleep episodes did not affect NREM sleep episode duration (P = 0.59 and 0.82, respectively; Fig. 2a ), but increased the probability of NREMtoREM sleep transitions (by ~80% and 1%, respectively, in ChETA compared with control mice; P = 0.048 and 0.039, respectively; Fig. 2b) . In contrast, we found that optical 20Hz stimulation of MCH neurons at the onset of REM sleep episodes significantly extended their duration (+47%) in ChETA transduced compared with control mice (P = 0.014; Fig. 2c ), whereas 1Hz stimulation had no effect (P = 0.49; Fig. 2c ). Notably, the EEG power spectrum of REM sleep (P = 0.45; Fig. 2d ChETA, 0.40 ± 0.013 mV 2 ; P = 0.13).
To rule out the possibility that the observed effects of MCH neu rons on REM sleep were a result of potentially unnatural synchrony among ChETAdriven MCH neurons, we used the ChR2 mutant step function opsin (SSFO) 30 . Activation of SSFO with a single blue light pulse increases excitability of targeted cells through sustained depolarization until SSFO is deactivated (typically by a yellow light pulse) 30 . Tg(Pmchcre) mice were transduced with AAVdjDIOSSFO EYFP in the lateral hypothalamus and zona incerta area with similar efficiency as for ChETA virus (Online Methods). Using wholecell voltageclamp recordings, we found that SSFOmediated activation of MCH neurons (50ms light pulses at 0.1 Hz) induced prolonged inward currents that were rapidly terminated by a single pulse of yellow light (50ms pulse width; Fig. 3a ). This produced a substan tial membrane depolarization that could be maintained for several minutes (>5 min; Fig. 3a,b) . To further assess the hyperexcitability of MCH neurons following SSFO activation, we used intracellular current injection to 'replay' a previously recorded current trace while recording the spontaneous synaptic inputs to MCH neurons in whole cell currentclamp mode. We found that, following SSFO activation, MCH neurons significantly increased their firing activity by ~4.5fold as compared with the deactivated state (P = 0.0008; Supplementary  Fig. 5 ). Notably, SSFOinduced spikes waveforms were indistinguish able from spontaneously occurring spikes ( Supplementary Fig. 5b ). Next, we used SSFO to study whether increasing excitability of MCH cells would extend REM sleep duration in freely moving mice (Online Methods and Supplementary Fig. 4a ). Indeed, we found that optical activation of SSFOexpressing MCH neurons during REM sleep significantly increased REM duration (+41%, P = 0.022; Fig. 3c ),
whereas it had no significant effect during NREM sleep (P = 0.40; Fig. 3d ). Together with our previous results ( Fig. 2c) , these findings provide evidence that activation of MCH neurons selectively extends the duration of REM, rather than NREM, sleep episodes.
Silencing of MCH neurons slows REM sleep theta rhythm
To assess whether activity of MCH neurons is necessary for natu ral REM sleep, we employed halorhodopsin (eNpHR3.0) [31] [32] [33] to transiently and reversibly silence MCH neurons. We targeted the expression of eNpHR3.0EYFP to MCH neurons by injecting AAVdj DIOeNpHR3.0EYFP in the lateral hypothalamus and zona incerta area of Tg(Pmchcre) mice (Online Methods). Using patchclamp recordings performed in acute hypothalamic slices, we found that yel low illumination (593 nm) resulted in outward photocurrents (steady state mean, 138.2 ± 48.4 pA; Fig. 4a,b ) and a strong hyperpolarization (27.4 ± 6.4 mV; Fig. 4a,b ) in eNpHR3.0expressing MCH neurons. To study the effect of a rapid and reversible silencing of MCH neurons on REM sleep, we bilaterally delivered continuous yellow illumina tion (593 nm) to the lateral hypothalamus and zona incerta area at the onset of REM sleep episodes (Supplementary Fig. 4a ). We found that optogenetic silencing of MCH neurons during REM sleep did not significantly reduce its duration (eNpHR3.0, 67.2 ± 4.4 s; EYFP, 60.2 ± 5.2 s; P = 0.337), but rather induced a shift in the dominant theta peak frequencies toward slower oscillations ( Fig. 4c-f ). This was character ized by a significant reduction of 6-9Hz theta power concomitant to an increase of 3-5Hz slow theta power (P = 0.003; Fig. 4g ) that occurred 8.31 ± 3.72 s after the light onset. Delta rhythms (0.5-4 Hz) remained unchanged during silencing of MCH neurons (eNpHR3.0, 0.28 ± 0.015; EYFP, 0.24 ± 0.016; P = 0.094). Similar to ChETA and SSFO experiments, muscle tone was not affected by optogenetic These results were further confirmed using archaerhodopsin (ArchT) 34 , a lightdriven proton pump (P = 0.017; Fig. 4h and Supplementary Fig. 6 ). Indeed, we found that the number of slow theta oscillations was significantly increased (by ~10 fold) during optogenetic silencing of MCH neurons in eNpHR3.0 expressing MCH neurons compared with neurons from control mice (P = 0.010; Fig. 4h) . Notably, the observed slow theta oscillations were not artificial because they occurred during spontaneous REM sleep, although less frequently, in all recorded mice, as detected using an unbiased waveform recognition algorithm (Fig. 4i,j and Online Methods). Taken together, these results indicate that silencing of MCH neurons decreases theta peak frequency (that is, REM sleep quality), rather than duration, of REM sleep episodes.
MCH neurons release GABA
How do MCH neurons modulate downstream sleepwake circuits? Subpopulations of MCH neurons express the vesicular GABA trans porter, cocaine and amphetamineregulated transcript (CART), Nesfatin1 and/or MCHrelated peptides 16, 20, [35] [36] [37] ; however, it remains unclear whether the firing of MCH neurons releases GABA and neu ropeptides. To determine the role of MCH peptide in sleep, we optoge netically stimulated MCH neurons in mice lacking the MCH receptor 1, MCHR1 (Tg(Pmchcre); Mchr1 −/− ; Supplementary Fig. 3b ). Note that MCHR1 is the only MCH receptor that is expressed in mice 38 . We found that optical activation of MCH neurons at 20 Hz extended REM sleep episodes similarly in both Tg(Pmchcre); Mchr1 −/− and Tg(Pmchcre) mice (P = 0.020; Fig. 5a ), suggesting that GABA and other neurotransmitters and modulators, rather than MCH peptide, are important for acute extension of REM sleep by MCH cell fir ing. Using fluorescence in situ hybridization labeling of Gad67 (also known as Gad1) mRNA combined with immunolabeling of MCH ( Fig. 5b and Online Methods), we found that 84.86 ± 2.18% (315 of 386 cells, n = 9 slices, n = 4 mice) of MCH cells expressed Gad67 and 17.09 ± 2.06% of MCH cells did not express Gad67, suggesting that a large majority of MCH neurons may release GABA.
We then functionally assessed whether MCH neurons release GABA. Anatomical mapping revealed dense ChETAexpressing MCH terminals in the TMN, in close apposition to the wakepromoting histaminergic neurons (Fig. 5c) 39 . We functionally mapped this lateral hypothalamus MCH →TMN circuit using optogenetics in brain slices from control Tg(Pmchcre) mice and Tg(Pmchcre); Mchr1 −/− mice transduced with ChETA virus. In both mouse models, optogenetic stimulation of the lateral hypothalamus MCH →TMN circuit routinely evoked bicucullinesensitive inhibitory postsynaptic currents (IPSCs) in postsynaptic histaminergic and nonhistaminergic neurons (P < 0.001; Fig. 5d,e and Supplementary Fig. 7) . IPSC latencies were typically short, consistent with monosynaptic connections 25, 40 , and did not differ between Tg(Pmchcre) and Tg(Pmchcre); Mchr1 −/− slices (Tg(Pmchcre), 2.16 ± 1.61 ms; Tg(Pmchcre); Mchr1 −/− , 5.36 ± 2.90 ms; P = 0.58).
The release of neuropeptides is thought to require the temporal proximity of multiple action potentials 41 . During optogenetic stimu lation, not all light flashes evoked an IPSC, consistent with the low release probability at central synapses 40 . Nevertheless, in Tg(Pmch cre) mice, 20Hz stimulation increased IPSC frequency relative to baseline (P < 0.05; Fig. 5f,g) . However, when repeated in Tg(Pmch cre); Mchr1 −/− mice, the effect of 20Hz stimulation on IPSC frequency was no longer significant (P = 0.16; Fig. 5g ). Because amplitudes of optically evoked IPSCs were similar in Tg(Pmchcre) and Tg(Pmch cre); Mchr1 −/− mice (P > 0.05; Fig. 5g ), the effect of MCHR1 dele tion on IPSC frequency suggests a possible presynaptic facilitation of GABAergic transmission by MCH peptide activation of its receptor.
MCH neurons modulate multiple targets
What are the downstream targets of MCH neurons for modulation of REM sleep? Our results, and those of others, suggest that MCH neurons exert an inhibitory action on postsynaptic targets, includ ing the wakepromoting histaminergic neurons located in the TMN (Fig. 5) , as well as other targets located in the septum and dorsal raphe 27, 42 . To test this hypothesis, we optogenetically activated ChETAexpressing MCH terminals in the tuberomammillary nuclei (lateral hypothalamus MCH →TMN), medial septum (lateral hypothalamus MCH →medial septum) or dorsal raphe (lateral hypothalamus MCH →dorsal raphe; Fig. 6a,b and Supplementary  Fig. 8 ). We found that optogenetic stimulation of both lateral hypothalamus MCH →TMN and lateral hypothalamus MCH → medial septum circuits significantly increased the duration of Fig. 6b ). The EEG power spectrum of REM sleep episodes remained unchanged during these experiments (medial sep tum, P = 0.79; TMN, P = 0.27; dorsal raphe, P = 0.73; Fig. 6c ). These results reveal two distinct downstream circuits through which MCH neurons modulate REM sleep episode.
DISCUSSION
Using two distinct activating opsins (ChETA and SSFO) for stimula tion of MCH neuron firing rates 21 , we found that acute activation of MCH neurons selectively modulated REM sleep state. Consistent with the neuroanatomical distribution of MCH neurons (Fig. 6a) 27 and the MCH receptor 27, 43, 44 , our results suggest that lateral hypothalamus MCH →TMN and lateral hypothalamus MCH →medial septum circuits represent two distinct pathways mediating MCH neuron control of REM sleep state. None of the optogenetic manipula tions affected the duration of NREM sleep episode, which is consistent with the discharge of MCH neuron during spontaneous REM, rather than NREM, sleep 21 .
To functionally map the underlying circuit, we first confirmed that MCH neurons expressed a vesicular GABA transporter 16 . We then showed that electrical activity in MCH neurons elicited GABA A mediated IPSCs in postsynaptic neurons in vitro, revealing a local inhibitory lateral hypothalamus MCH →TMN connection in the hypothalamus. Notably, TMN histaminergic neurons are silent dur ing both NREM and REM sleep, but display arousalspecific neuronal activity 39 , particularly during REM sleep to wake transitions. Thus, we could speculate that activation of the lateral hypothalamus MCH → TMN circuit extends the duration of REM sleep episode by maintain ing an inhibitory tone that delays the reactivation of histamine neu rons 39 , as well as other hypothalamic 45, 46 and extrahypothalamic [2] [3] [4] [5] [6] arousal centers shown to be quiescent during REM sleep.
Consistent with previous studies 47, 48 , we found that activation of the lateral hypothalamus MCH →medial septum, but not lateral hypothalamus MCH →dorsal raphe, circuit was sufficient to extend the duration of REM sleep episode, suggesting that MCH neurons provide a functional input to septohippocampal circuits in which they par ticipate to the stabilization of hippocampus theta rhythm and cortical oscillations (around ~7 Hz) during REM sleep (as shown in Fig. 4 ). This hypothesis is further supported by our silencing experiment, in which we found that rapid and reversible silencing of MCH neurons only during REM sleep episodes reduced the frequency and ampli tude of theta oscillations in the hippocampus, which are a hallmark of REM sleep in mammals. Note that the silencing of MCH neurons did not reduce the duration of REM sleep episodes, suggesting that the termination of REM sleep episodes requires additional intra and/or extrahypothalamic circuits.
Experimental evidence suggests that activation of the MCHR1 enhances cognitive processing during wakefulness 49 and facilitates longterm plasticity at CA1 glutamatergic synapse in the hippo campus 50 , indicating that MCH neurons may affect sleepdependent cognitive processing through direct modulation of theta rhythm dur ing REM sleep. However, additional circuits are likely to be involved and further experiments are required to identify the mechanisms underlying the regulation of NREM and REM sleep states and their direct relevance in learning and memory.
The persistence of extended REM sleep episodes following MCH neuron activation in mice lacking known MCH receptors suggests that the MCH peptide may have a minor role in acute regulation of REM sleep, in contrast with longlasting activation of MCH neurons or MCHR1. Indeed, previous pharmacological 15, 17 and optogenetic 18 studies have reported an increase of both NREM and REM sleep episode duration after cerebral infusion of MCH peptide or chronic optogenetic activation of MCH neurons. In contrast with our results, a previous study also observed an increase of NREM, as well as delta power, following optogenetic activation of MCH neu rons 18 . This is likely a result of different optogenetic stimulation pro cedures or genetic targeting strategies. Based on in vivo data showing that MCH neurons are primarily active during REM sleep 21 , we used a temporal and sleep state-specific optogenetic stimulation; opti cal stimulation (1-20 Hz) were delivered at the onset of NREM or REM sleep and terminated at the following behavioral transition. In contrast, the previous study 18 used a chronic random stimulation pro cedure in which optical stimulations were delivered at fixed interval (10 Hz, 1 min every 5 min for 24 h) independent of the behavioral state (that is, wake, NREM or REM sleep) of the animals. Although we did not observe an extension of NREM sleep episode in our acute experiment, it is possible that chronic activation of MCH neurons results in a longlasting activation of MCH or GABA A receptors, as well as receptors for transmitters/modulators produced by MCH neurons (Nesfatin1, CART) 20, 35, 37 , that eventually modulate NREM sleep, as reported in pharmacological experiments 15, 17 . Whether this reflects a physiological condition occurring during spontaneous sleep remains to be determined. Furthermore, we generated a new mouse model, Tg(Pmch-Cre), to target the entire MCH neuron population in the lateral hypothalamus and zona incerta area, whereas they used a promoterspecific AAV that limited the transduction of opsin to half of the MCH neuron population (dorsal to the lateral hypothalamus). Thus, it is likely that this partial targeting limited their optogenetic modulation of REM sleep, however, we cannot rule out the existence of anatomical subpopulations of MCH neurons with distinct modula tory function on NREM sleep.
Overall, our results, and those of others [14] [15] [16] , together with the neuroanatomical distribution of MCH neuron terminals, suggest that MCH neurons represent a subset of inhibitory cells outside the brain stem that stabilize REM sleep state, possibly through the distributed inhibition of arousal centers located in hypothalamus, forebrain and brainstem structures 7, 12 . Further functional dissections of NREM and REM sleep circuits in the mammalian brain will undoubtedly support the identification of selective targets that protect the integrity, structure and function of sleep in healthy subjects and pathological conditions.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
generation of Pmch-cre transgenic mice. To restrict Cre expression to MCH neurons, we used a BAC clone containing the fulllength pro-melaninconcentrating hormone (Pmch) gene (RP23129A21) with upstream and down stream flanking sequences of 108 kb and 89 kb, respectively. BAC DNA was prepared and electroporated into E. coli strain SW102 as required 51 . An NLS Cre PolyA construct (pML78, M. Lewandowski, National Cancer Institute) was targeted to replace the ATG translational start codon of Pmch exon 1 and correct insertion was verified by PCR and sequencing (5′ recombineering homology: TG AAAGTTTTCATCCAATGCACTCTTGTTTGGCTTTATGCAAGCATCAAA; 3′ recombineering homology: CTGCAGAAAGATCCGTTGTCGCCCCTTCTC TGGAACAATACAAAAACGAC; Fig. 1a ). All DNA fragments used for recom bineering were generated with the FastStart High Fidelity PCR System (Roche). The modified BAC insert was excised by NotI digestion, purified and used for pronuclear injection.
Heterozygous Tg(Pmchcre) mice were maintained on a C57BL/6 genetic back ground by intercross breeding. Tg(Pmchcre) males were used for sleep recordings and optogenetic stimulations, whereas both sexes were used for in vitro electro physiology. No detectable effects on phenotype were found. Mice were housed in individual customdesigned polycarbonate cages at constant temperature (22 ± 1 °C), humidity (30-50%) and circadian cycle (12h lightdark cycle, start ing at 8 a.m.). Food and water were available ad libitum. Mice were treated accord ing to protocols and guidelines approved by McGill University and the Canadian Council of Animal Care. characterization of Pmch-cre transgenic mice. To determine the specifi city of the Cre recombinase expression, Tg(Pmchcre) mice were crossed with RosaCAGLSLtd TomatoWPRE mice (line Ai9, Jackson Laboratories). Quantification of colocalization was performed on adjacent sections containing the lateral hypothalamus as described below. Some ectopic expression was found in the septum, the cortex and the cerebellum.
Plasmid and viral targeting. Ef1αDIOeNpHR3.0EYFP, Ef1α DIOChETA EYFP, Ef1αDIOSSFOEYFP or control Ef1αDIOEYFP plasmids were kindly provided by K. Deisseroth (Stanford University) and packaged in adeno associated (AAV) DJ serotype 52 at the Vollum Vector Core. As reported previ ously 3 , viruses were stereotactically infused (0.8 µl total at 50 nl min −1 ) bilaterally in the lateral hypothalamus (anteroposterior, −1.50 mm; mediolateral, ±0.9 mm; dorsoventral, 5.35 mm) of Tg(Pmchcre) mice anesthetized with isoflurane (5% induction, 1% maintenance). Tg(Pmchcre) mice were randomly assigned to viral injection. Viral transduction efficiencies of MCH neurons were similar for all viruses.
In vitro electrophysiology. Postnatal day 15-18 Tg(Pmchcre) mice were stereo tactically injected into the lateral hypothalamus (anteroposterior, −1.45 mm; mediolateral, ±0.5 mm; dorsoventral, 5.35 mm). 3-5 weeks after virus transduc tion, mice were deeply sedated using isoflurane, decapitated, and the brain was rapidly removed and cooled in icecold highsucrose cutting solution contain ing 252 mM sucrose, 26 mM NaHCO 3 , 2.5 mM KCl, 4 mM MgCl 2 , 1.25 mM KH 2 PO 4 , 0.1 mM CaCl 2 , 10 mM glucose. All mice were killed during the light phase and the slices were used during the afternoon. Coronal slices were cut using a vibratome (VT1000S, Leica) and allowed to recover for ~1.5 h at 22 ± 1 °C in artificial cerebrospinal fluid containing124 mM NaCl, 5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM MgSO 4 , 2 mM CaCl 2 , 26 mM NaHCO 3 , and 10 mM dextrose saturated with 95% O 2 and 5% CO 2 (pH ~7.3, 300-310 mOsm). Coronal brain slices were transferred to the recording chamber and perfused continuously with oxygenated ACSF (1.5-2 ml min −1 ) maintained at 22 ± 0.5 °C. Cellular morphology and fluorescence were visualized with an upright fluorescent micro scope (BX51WI, Olympus) equipped with a 40× waterimmersion objective, dif ferential interference contrast optics, infrared differential interference contrast and a nearinfrared fluorescence camera (EXi Blue, QImaging). Histaminergic neurons were identified on the basis of previously published electrophysiological characteristics 5 and immunohistochemical analyses (see below). electrophysiological recordings and data analysis. Micropipettes were pre pared from borosilicate glass capillaries (1.0mm outer diameter, 0.58mm inner diameter) using a horizontal puller (P97, Sutter Instruments), and had tip resistances of 3-8 MΩ. Somatic wholecell current and voltageclamp recordings from MCH neurons were obtained using patch recording pipettes containing 120 mM potassium gluconate, 20 mM KCl, 10 mM N2hydroxyethylpiperazine N′2ethanesulfonic acid (HEPES), 7 mM phosphocreatine diTris, 2 mM MgCl 2 , 0.2 mM ethylene glycobis (βaminoethyl ether)N,N,N′,N′tetraacetic acid (EGTA), 4 mM Na 2+ ATP, 0.3 GTPTris (pH adjusted to 7.20-7.26 using KOH, 275-85 mOsm). In TMN experiments, voltageclamp recordings were obtained in patch recording pipettes containing 70 mM potassium gluconate, 70 mM KCl, 2 mM NaCl, 2 mM MgCl 2 , 10 mM HEPES, 5 mM QX314, 1 mM EGTA, 4 mM MgATP, 0.3 mM GTP and 0.1% mM biocytin (pH 7.2-7.26, 275-285 mOsm). Inhibitory postsynaptic currents were routinely recorded in the presence of the AMPA receptor antagonist CNQX (20 µM) and low concentrations of 4AP (10 µM) to increase the reliability of the evoked IPSC 4 . In vitro electrophysiologi cal data were discarded if intrinsic cell properties (resting membrane potential, input resistance) were more than 3 s.d. outside of the group mean and/or access resistance changed by >15%, as monitored by series resistance measurements throughout the course of the experiment (mean series resistance was 17 ± 1 MΩ). Axopatch 700B amplifier was used for all currentclamp and voltageclamp recordings and signals were digitized (Axon Instruments, Digidata 1322A) and sampled at 20 kHz for storage on harddisk using pClamp 10.2 software pack age. Currentclamp recordings were filtered at 10 kHz, and voltageclamp data were filtered at 2 kHz.
For optogenetic stimulation, square pulses of blue (473 nm) or yellow (593 nm) light, respectively, were delivered using lasers (Laserglow) connected to a 200µm optical fiber and triggered via a builtin transistortransistor logic circuit controlled by Clampex 10.3 software package. Light intensity was tested before each experiment, and was calibrated to emit 30-40 mW from the tip of the optical fiber.
Electrophysiological characteristics of MCH neurons were quantified using Clampfit 10.3 software package. Action potential measurements were derived from the first spike in response to a depolarizing intracellular current injection (typically 40-60 pA), and action potential amplitude was calculated from resting membrane potential. Action potential duration and afterhyperpolarizations were calculated from action potential threshold, and input resistance and rectification ratio was calculated in response to a −100 pA and −200 pA hyperpolarizing cur rent pulse, respectively, from a holding voltage of −60 mV. Inhibitory postsynaptic current frequency and amplitude analyses were quantified in Clampfit 10.3 using event threshold detection using predefined criteria (a crit > 7 pA) over three non consecutive 5s samples of baseline and stimulation conditions, and all detected events were subsequently visually validated. Membrane potentials reported here were corrected offline for the liquid junction potential, estimated at ~7.6 mV using JpCalc (Axon Instruments).
In vivo optrode recording. Simultaneous optogenetic stimulation and extracel lular recording of lateral hypothalamus neurons from Tg(Pmchcre) mice trans duced with AAVdjChETAYFP were carried out using glass pipette recording, as described elsewhere 6 . Briefly, recordings were conducted while gradually lowering the pipette (loaded with 0.5 KCl) in small increments to the lateral hypothalamus area. The optical fiber was coupled to a 473nm laser (~40 mW). Singleunit recordings were recorded in urethaneanesthetized mice. Data were bandpass filtered at 300 Hz low/3 kHz high using an extracellular amplifier (Cygnus technologies) and acquired on a computer using Spike 2 software.
Pharmacological manipulations. Drugs were stored in frozen stock solution and diluted to final concentrations in ACSF before recordings. In TMN experi ments, bicuculline methiodide (10 µM) was used to block GABA A receptors. All salts and powders were purchased from SigmaAldrich, except for 6cyano7 nitroquinoxaline2,3dione (CNQX), DL(±)2amino5phosphonopentanoic acid (AP5) and bicuculline methiodide (10 µM) (Ascent Scientific).
In vivo polysomnographic recordings. As described previously 53 , 9weekold Tg(Pmchcre) and Tg(Pmchcre); Mchr1 −/− mice were chronically implanted with bilateral fiber implants 7 above the lateral hypothalamus (Doric Lenses; antero posterior, 1.40; mediolateral, 0.95 mm; dorsoventral, 4.6 mm) and EEG/EMG connector secured to the skull with C&B Metabond (Patterson Dental) and dental cement (Patterson Dental). EEG and EMG signals were recorded from two pairs of electrodes inserted on the skull and the neck muscle, respectively. After 2 weeks npg of recovery from surgical procedure and 1 additional week of habituation to the EEGEMG recording set up, optical patch cords and zirconia sleeves (inner diameter = 1.25; Doric Lenses) were connected permanently to the fiber implants. Black nail polish and black furcation tubing were used to blackout light refraction from the implant and the patch cord, respectively, during the optogenetic stimulation.
For circuit mapping experiments, a bilateral optical fiber implant was implanted above the TMN (anteroposterior, −2.18 mm; mediolateral, ±1.12 mm; dorsoventral, −5.25 mm; n = 4). A unilateral optical fiber implant with a 6° angle was implanted above the medial septum (anteroposterior, 0.86 mm; mediolateral, 0.60 mm; dorsoventral, −3.62 mm; n = 6). A unilateral optical fiber implant with a 12° angle was implanted above the dorsal raphe (anteroposterior, −4 mm; mediolateral, 1 mm; dorsoventral, −3.40 mm; n = 4). Position of optical fibers was verified for each mouse included in the study (Supplementary Fig. 8) . Mice with no viral expression, abnormal sleepwake cycle (3 s.d. outside group mean) or optical fiber implants outside the target area were discarded from the study. Based on these criteria, 4 ChETA, 2 EYFP, 2 NpHR3.0 transduced Tg(Pmchcre) mice and 1 ChETA transduced Tg(Pmchcre); Mchr1 −/− mouse were excluded from the study.
Polysomnographic recording. All sleep recordings took place during the second part of the light phase (12-7 p.m.; light onset, 8 a.m.). EEG and EMG signals from electrodes were amplified (Grass Instruments) and digitized at 512 Hz (Vital Recorder, Kissei Comtec) as previously described 3 . Polysomnographic recordings were scored and analyzed using sleep analysis software (SleepSign for Animal, Kissei Comtec). All scoring was performed manually by 5s epochs as previously described 53, 54 . Briefly, we defined wakefulness as desynchronized low amplitude EEG and high tonic EMG activity with phasic bursts, NREM sleep as synchronized, highamplitude, lowfrequency (0.5-4 Hz) EEG and highly reduced EMG activity compared with wakefulness with no phasic bursts, and REM sleep as having a pronounced theta rhythm (6-9 Hz) and a flat EMG. As previously described 3 , polysomnographic scorings were tested by two inde pendent scorers and was found to lie within a 95% confidence interval.
Spectral eeg/emg analysis. EEG power spectra were computed for 6-15 stim ulated events per mouse (>20s duration). Power spectra and timefrequency power spectra were calculated in Matlab with the Chronux toolbox 59 using a 5s sliding window (0.062s increments). To normalize the data, all power spec tral densities at the different frequency ranges, that is, delta (0.5-4 Hz), slow theta (35 Hz) or theta (6-9 Hz), were expressed as relative values to the total power of the same event. EMG power was calculated on the basis of a 30-100Hz range frequency.
Unbiased automatic detection of an increase of power in the 3-5-Hz frequency band during Rem sleep. We automatically detected epochs when the EEG power in the 'slow theta' range was increased based on a detection thresh old established during the baseline recording period (Fig. 4h-j) . The analysis was performed as follows. First, theta = 6-9 Hz and slow theta = 3-5 Hz were defined and kept constant for every mouse included in analysis. Second, for each mouse, the average slow theta/theta power ratio was calculated for all REM epochs (5s duration each) occurring during baseline recording at the corresponding circadian time point (12-7 p.m.). Spectral power of each 5s REM epoch was calculated in Matlab using the Chronux toolbox 55 and the slow theta/theta ratio for each epoch was obtained from the summed spectral power from the specified slow theta frequency range divided by that of the theta fre quency range. The average slow theta/theta power ratio and s.d. for all baseline REM epochs was then calculated. The threshold slow theta/theta power ratio for each mouse used for subsequent analysis during REM inhibition experi ments (below) was defined as the average baseline REM slow theta/theta power ratio + 2 s.d. Third, for REM silencing experiments, the slow theta/theta power ratio was calculated for each REM 5s epoch as described for baseline record ings. Each epoch was identified as having a slow theta/theta power ratio above or below the defined threshold calculated as described above. Thus, for each mouse the percentage of detected relative to nondetected epochs was quanti fied and average power spectra values were calculated from all nondetected or detected epochs. optogenetic stimulation. All optogenetic stimulations (5ms pulses, 1-20 Hz) were generated by a waveform generator (Master 9) that triggers two bluediode lasers (473 nm, LaserGlow). Acute optogenetic stimulation consistently started ~10 s after the onset of a stable NREM or REM sleep episodes and terminated at the next behavioral transitions (Supplementary Fig. 4c ). During the experiment, frequencies of optogenetic stimulations (1 and 20 Hz) were randomly delivered at either NREM or REM sleep onset in Tg(Pmchcre) and control mice. For the stimulation of MCH projections in the medial septum, TMN or dorsal raphe, 20 Hz stimulations were used. For NREM sleep experiments, we chose to dis card microarousals (<1s) during NREM sleep while stimulating and terminated stimulation only after the onset of a REM or a wake event >5 s. To circumvent overstimulation of MCH neurons during prolonged NREM sleep period, 5ms light pulses (1 Hz or 20 Hz) were delivered for 5 s every 10 s and this cycle was repeated until the mouse exhibited a state transition (Supplementary Fig. 4b) .
For the SSFO experiment, we applied 50ms blue light pulses every 10 s over the entire NREM or REM sleep episode and a single 50ms yellow light pulse to deactivate SSFO at the end of the episode (Fig. 3) . For silencing experiment, constant light delivery was provided by a yellowlight laser (593 nm; LaserGlow) split into two patch cords.
Immunohistochemistry. Mice were deeply anesthetized with ketamine/xylazine/ acepromazide (100, 16 and 3 mg per kg, respectively, intraperitoneal injection) and perfused transcardially with 1× phosphatebuffered saline (PBS) with 0.1% heparine (vol/vol, pH 7.4), followed by 4% paraformaldehyde (vol/vol) in PBS. Brains were extracted, postfixed overnight in the same fixative at 4 °C, and cryo protected in PBS with 0.1% azide (vol/vol) and 30% sucrose (vol/vol) for an additional 24 h at 4 °C.
For double immunolabeling (Fig. 1b,d) , 25µmthick brain sections from virally transduced mice were washed (PBSTriton (PBST), 10 min, 22 ± 1 °C), incubated in a blocking solution (PBST with 4% bovine serum albumin, BSA) for 1 h at 22 ± 1 °C and then in a goat antibody to proMCH (SC14509, 1:1,000, Santa Cruz Biotech) and in a rabbit antibody to YFP (Ab290, 1:5,000, Abcam) in block solution (4% BSA) at 4 °C for ~48 h. After three 10min washes in PBST, sections were incubated in a solution of Alexa 555-conjugated donkey antibody to goat IgG (1:1,000, A21432, Invitrogen) or Alexa 488-conjugated donkey antibody to rabbit IgG (1:1,000, A21206, Invitrogen) in blocking solution (4% BSA) for 1 h at 22 ± 1 °C. Sections were washed three times for 10 min in PBST, mounted and coverslipped with FluoromountG (Southern Biotech) and quantified for MCH YFP colocalization in adjacent lateral hypothalamus sections.
To verify that histamine was expressed in recorded TMN neurons, patch pipettes were filled with 0.1% biocytin (vol/vol, Sigma). Coronal brain slices were transferred to 4% paraformaldehyde in PBS for >24 h and incubated for 30 min in 0.3% PBST for 1 h, rinsed five times (5 min per wash) in 0.1% PBST and then incubated in 0.1% PBST with 1% BSA for 1 h. Slices were then trans ferred to the same solution containing 1% BSA with rabbit antibody to histamine decarboxylase (1:500, Acris, EUD2601) at 4 °C. Slices were then washed (five times for 10 min in 0.1% PBST), incubated in a secondary antibody (antibody to rabbit Alexa 555 for histamine labeling and StrepdavidinB conjugated with Alexa 649 for biocytin labeling) for 1.5 h at 22 ± 1 °C, washed (five 10min washes in PBS) and mounted on glass microscope slides.
In situ hybridization and immunocytochemistry. Tg(Pmchcre) mice were deeply anesthetized with 5% isoflurane (vol/vol) and decapitated. Brains were extracted, quickly frozen in isopentane at −30° C and stored at −80° C for at least 24 h. Coronal brain sections (16 µm) were mounted onto glass slides and stored at −80° C. Lateral hypothalamus sections were transferred into cold 4% paraformaldehyde for 20 min, followed by five 5min washes in 0.1 M PBS, and then incubated in PBS containing 0.3% H 2 O 2 (vol/vol) for 10 min at 22 ± 1 °C, followed by five 5min washes in PBS. Acetylation was induced using 0.1 M TEA buffer containing 0.25% acetic anhydride (vol/vol) for 10 min, followed by five 5min wash in PBS. Sections were then dehydrated for 10 min and placed in a humid chamber saturated with formamide. Sections were incubated in a pre hybridization buffer (40% formamide (vol/vol), 10 mM TrisHCl, pH 8.0, 200 µg ml −1 yeast tRNA, 10% dextran sulfate (vol/vol), 1× Denhardt's solution, 600 mM NaCl, 1 mM EDTA, pH 8.0) for 2 h at 60 °C, and subsequently transferred to a hybridization buffer including the antisense or sense GAD67 npg
